Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Polycystic Ovary Syndrome 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Kallmann Syndrome 1Hypogonadism 1Hyperprolactinemia 1Breast Neoplasms 1

Interventions

testosterone undecanoate 1testosterone 17 beta-cypionate 1Testosterone Propionate 1Standard of Care 1Practice Guidelines as Topic 1Methyltestosterone 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hypogonadism × Gonadotropin-Releasing Hormone × Clear all
NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed
256 enrolled

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡